155 related articles for article (PubMed ID: 27648827)
21. Detection of p16INK4a promoter methylation status in non-small cell lung cancer by a fluorescence polarization assay.
Song Z; Zhou R; Li D; Chen Y; Liang P; Liu W; Zhang J
Diagn Mol Pathol; 2011 Sep; 20(3):138-42. PubMed ID: 21817906
[TBL] [Abstract][Full Text] [Related]
22. Role of p16 gene promoter methylation in gastric carcinogenesis: a meta-analysis.
Wang HL; Zhou PY; Liu P; Zhang Y
Mol Biol Rep; 2014 Jul; 41(7):4481-92. PubMed ID: 24610350
[TBL] [Abstract][Full Text] [Related]
23. Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma.
Wang Y; Cheng J; Xu C; Liu S; Jiang S; Xu Q; Chen X; Zhuang H; Lu F
Liver Int; 2012 Mar; 32(3):420-8. PubMed ID: 22192146
[TBL] [Abstract][Full Text] [Related]
24. Role of RASSF1A promoter methylation in the pathogenesis of ovarian cancer: a meta-analysis.
Si JG; Su YY; Han YH; Chen RH
Genet Test Mol Biomarkers; 2014 Jun; 18(6):394-402. PubMed ID: 24665911
[TBL] [Abstract][Full Text] [Related]
25. The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance.
Chen M; Chen ZQ; Cui PG; Yao X; Li YM; Li AS; Gong JQ; Cao YH
Br J Dermatol; 2008 May; 158(5):987-93. PubMed ID: 18373711
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic regulation of p14ARF and p16INK4A expression in cutaneous and uveal melanoma.
Venza M; Visalli M; Biondo C; Lentini M; Catalano T; Teti D; Venza I
Biochim Biophys Acta; 2015 Mar; 1849(3):247-56. PubMed ID: 25497382
[TBL] [Abstract][Full Text] [Related]
27. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
Zhu R; Li BZ; Ling YQ; Zhang HP; Li H; Liu Y; Hu XQ; Zhu HG
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629
[TBL] [Abstract][Full Text] [Related]
28. [Methylation and expression of gene p16INK4a and RB in gastric carcinomas].
Zhao Y; Tian X; Du J; Zhang Y; Liu S; Lin J; Zheng J
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 35(4):382-5. PubMed ID: 12947553
[TBL] [Abstract][Full Text] [Related]
29. Promoter hypermethylation profile of ovarian epithelial neoplasms.
Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
[TBL] [Abstract][Full Text] [Related]
30. Methylation of the Suppressor Gene
Tramontano A; Boffo FL; Russo G; De Rosa M; Iodice I; Pezone A
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32183138
[TBL] [Abstract][Full Text] [Related]
31. Relationship between RAS Association Domain Family Protein 1A Promoter Methylation and the Clinicopathological Characteristics in Patients with Ovarian Cancer: A Systematic Meta-Analysis.
Wang H; Cui M; Zhang S; He J; Song L; Chen Y
Gynecol Obstet Invest; 2018; 83(4):349-357. PubMed ID: 29130987
[TBL] [Abstract][Full Text] [Related]
32. Relationships among folate, alcohol consumption, gene variants in one-carbon metabolism and p16INK4a methylation and expression in healthy breast tissues.
Llanos AA; Dumitrescu RG; Brasky TM; Liu Z; Mason JB; Marian C; Makambi KH; Spear SL; Kallakury BV; Freudenheim JL; Shields PG
Carcinogenesis; 2015 Jan; 36(1):60-7. PubMed ID: 25344837
[TBL] [Abstract][Full Text] [Related]
33. p16INK4A alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas.
Semczuk A; Boltze C; Marzec B; Szczygielska A; Roessner A; Schneider-Stock R
J Cancer Res Clin Oncol; 2003 Oct; 129(10):589-96. PubMed ID: 12920579
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic Role of RASSF1A and p16INK4a Promoter Gene Hypermethylation in Serum DNA of Lung Cancer Patients: Clinicopathological Significance.
El-Sherif WT; Sayed SK; Galal SH; Makhlouf HA; Hassan AT; Yousef HA
Egypt J Immunol; 2016 Jun; 23(2):1-16. PubMed ID: 28502129
[TBL] [Abstract][Full Text] [Related]
35. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.
Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y
Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of p16INK4a and p14ARF gene hypermethylation in human colon cancer.
Lee M; Sup Han W; Kyoung Kim O; Hee Sung S; Sun Cho M; Lee SN; Koo H
Pathol Res Pract; 2006; 202(6):415-24. PubMed ID: 16675157
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
38. Methylation status of the gene promoter of cyclin-dependent kinase inhibitor 2A (CDKN2A) in ovarian cancer.
Abou-Zeid AA; Azzam AZ; Kamel NA
Scand J Clin Lab Invest; 2011 Nov; 71(7):542-7. PubMed ID: 21728901
[TBL] [Abstract][Full Text] [Related]
39. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
40. Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients.
Sharma G; Mirza S; Prasad CP; Srivastava A; Gupta SD; Ralhan R
Life Sci; 2007 Apr; 80(20):1873-81. PubMed ID: 17383681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
